1076541

Samuel N. Lederman, M.D. — FEI 3010160490

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Palm Springs, FL (United States)

Additional Details

Clinical Investigator (CI)